I’ve recently joined the Journal of Commercial Biotechnology as managing editor. Drop me a line if you would like to make a submission.
The most recent issue, edited by Neil Henderson, has just been published:
Volume 13, Issue 3
Articles
| When should you fire the founder? | |
| William Bains |
| Constructing a processual model of communication in new product development from a multiple case study of biotechnology SMEs | |
| Jennifer Frahm, David C Ireland, Damian Hine |
| A maturing industry: Strategic patenting trends, US and academic dominance, and the global biotechnology landscape | |
| Gareth Williams |
| Measuring performance of field-medical programmes: Medical science liaison metrics consensus | |
| Jane Chin |
| The commercialisation of bioinformatics and the threat of open-source software | |
| Joseph F Greco |
| Intellectual property issues in nanotechnology | |
| Lars Genieser, Michael Gollin |
| Fostering the process of adoption of personalised medicine: A matter of communication or a matter of cost? | |
| Pedro Reinares Lara, Emma Gutierrez de Mesa |
| Changing hopes and concerns about gene therapy in Japan | |
| Darryl Macer, Yoshihiro Okada, Makoto Nakagawa, MaryAnn Chen Ng, Masakazu Inaba |
Legal and Regulatory Updates
| Legal and regulatory update | |
| John Wilkinson |